Ambulatory Versus Home Blood Pressure Monitoring in Obstructive Sleep Apnea

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-02-29

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Subjects referred to a sleep clinic had polysomnography (PSG), clinic BP measurements, 24-hour ABP monitoring and HBP monitoring using a device (Microlife WatchBP HomeN) that allows daytime (3 days, 2 duplicate readings/day) and automated nighttime BP measurement (3 nights, 3 readings/night).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnoea Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≤ 65 years
* Suspected OSA
* Treated or untreated for hypertension

Exclusion Criteria

* History of cardiovascular disease (heart failure, coronary heart disease, arrhythmia or stroke)
* History of asthma or chronic obstructive pulmonary disease (FEV1/FVC \<70%)
* History of diabetes mellitus, collagen diseases and sarcoidosis
* Serum creatinine \>1.6 mg/dl, proteinuria
* Previous treatment with CPAP
* Pregnancy or menstruation during the study
* Treatment with steroids, lithium or any other drugs affecting BP
* Change in antihypertensive treatment(if any) in the last 8 weeks before study entry

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

George S. Stergiou

Associate Professor of Medicine and Hypertension

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

First University Department of Respiratory Medicine, Sotiria Hospital

Athens, , Greece

Site Status RECRUITING

Hypertension Center, Third Department of Medicine, University of Athens, Greece

Athens, , Greece

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Greece

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Manos Alchanatis, Assoc. Prof. Respir. Medicine

Role: primary

George S Stergiou, MD